Kandou AI, Swiss-based specialist in high-speed, energy-efficient connectivity and system solutions for AI, closed a USD 225 million series A funding round. In connection with the round, Homburger advised Kandou AI, while Niederer Kraft Frey (NKF)
The European Company Lawyers Association (ECLA) has renewed its leadership team, unanimously reappointing Stéphanie Fougou as president for the next three years and naming Laure Lavorel and Teresa Mí
Bär & Karrer advised Dsm-firmenich, as the Swiss company active across the nutrition, health and beauty sectors entered into an agreement with private markets manager CVC to divest its Animal Nutrition & Health (ANH)
Walder Wyss advised the banking syndicate — consisting of Zürcher Kantonalbank as mandated lead arranger, coordinator, agent and lender and Basellandschaftliche Kantonalbank as lender — in connection with a club deal financing for Kantonsspital Aarau. The
Kellerhals Carrard advised RIVR — a Zurich-based autonomous robotics startup spun out of the Robotic Systems Lab of Professor Marco Hutter at ETH Zürich and now part of Amazon — as the company raised a total
Niederer Kraft Frey (NKF) advised Invision on the sale of its stake in AK Group, including its subsidiaries SkySale Schweiz (operator of the e-commerce platform Apfelkiste.ch) and Marein, to listed Swiss telecommunications specialist Mobilezone.
Welcome to Signed, Sealed, Weekend, our weekly newsletter recap. Check out the news of the week: · Kellerhals Carrard Startup & VC Desk advised Vsquared Ventures and World Fund, in connection with their role as lead
Baker McKenzie advised Kulm Hotel, a luxury hotel located in St. Moritz, on a club deal financing. In connection with the deal, Advestra represented UBS Switzerland as coordinator, agent and lender, and Raiffeisen Switzerland as
Homburger advised medical communications specialist Health & Wellness Partners (HWP Group) on the acquisition of Global Market Access Solutions (GMAS), a gloablly active market access and health economics consultancy. The Homburger team The Homburger team
Walder Wyss advised Nasdaq-listed CRISPR Therapeutics, as the Switzerland-based biopharmaceutical company issued a USD 600 million aggregate principal amount of convertible senior notes. The convertible senior notes were offered in a private offering to qualified institutional
